2025 starts out with this news release below from IDA Ireland. It is wonderful to see new job announcements. The biopharmaceutical industry continues to thrive in Ireland. MSD Ireland
As part of its long-term plans in Ireland, MSD has agreed to acquire the WuXi Vaccines manufacturing facility located in #Dundalk, Co Louth. The acquisition signifies an investment of over €500 million, which comes on the back of the company’s recent announcement of a €1 billion investment across its sites in Carlow and Dunboyne, just last year. MSD and WuXi Vaccines will now begin an official handover process which aims to be completed in the first half of 2025. ▪️ MSD's acquisition of the WuXi Vaccines Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its footprint to eight locations nationwide with over 3,000 currently employed across the country. ▪️ Together with the acquisition, the company plans to add approximately 1,000 jobs over the coming year, including 150 additional #jobs at the newly acquired Dundalk facility. "Our partnership with MSD Ireland spans nearly 50 years, and it’s exciting to see the company continue to both deepen and broaden its roots all across the country, expanding to its new location in Dundalk” - Michael Lohan, CEO of IDA Ireland Read more here: https://lnkd.in/emVFQ-28 #InvestInIreland #InvestInExtraordinary